Drugs / DTPa-HBV-IPV/Hib
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01457508 | Jan 1999 → Mar 2000 | diphtheria, hepatitis B virus infection, pertussis, poliomyelitis +1 | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTPa-HBV-IPV/Hib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01457508 ↗ |
| Known as | Infanrix hexa | “DTPa-HBV-IPV/Hib (Infanrix hexa™) vaccine” NCT01457508 ↗ |
| Modality | Vaccine | “DTPa-HBV-IPV/Hib (Infanrix hexa™) vaccine” NCT01457508 ↗ |